药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Segesterone acetate
The metabolism of Segesterone acetate can be increased when combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Trestolone acetate
The risk or severity of edema formation can be increased when Trestolone acetate is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Testosterone enantate benzilic acid hydrazone
The risk or severity of edema formation can be increased when Testosterone enantate benzilic acid hydrazone is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Metenolone
The risk or severity of edema formation can be increased when Metenolone is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Atamestane
The risk or severity of edema formation can be increased when Atamestane is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Mibolerone
The risk or severity of edema formation can be increased when Mibolerone is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Formestane
The risk or severity of edema formation can be increased when Formestane is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Testosterone succinate
The risk or severity of edema formation can be increased when Testosterone succinate is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Epitestosterone
The risk or severity of edema formation can be increased when Epitestosterone is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Fluasterone
The risk or severity of edema formation can be increased when Fluasterone is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
16-Bromoepiandrosterone
The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Mesterolone
The risk or severity of edema formation can be increased when Prednisolone acetate is combined with Mesterolone.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Nandrolone
The risk or severity of edema formation can be increased when Prednisolone acetate is combined with Nandrolone.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Nandrolone decanoate
The risk or severity of edema formation can be increased when Prednisolone acetate is combined with Nandrolone decanoate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Phenylacetic acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Glycerol phenylbutyrate
The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Phenylbutyric acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Alcuronium
The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Gallamine
The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Atracurium
The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Prednisolone acetate.